Last reviewed · How we verify

NCT03506880

Project MADD - NIH Underage DUI and Ride

Completed NA Results posted Last updated 29 June 2023
What this trial tests

NA trial testing MADD Materials in Underage Drinking in 2,352 participants. Completed in 30 April 2022.

Timeline
17 November 2017
Primary endpoint
30 April 2022
30 April 2022

Quick facts

Lead sponsorPenn State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment2,352
Start date17 November 2017
Primary completion30 April 2022
Estimated completion30 April 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Penn State University

Who can join

Adults 15 to 18, any sex, with Underage Drinking or Driving Under the Influence. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Typical Weekend Drinking (DDQ) Primary · Baseline, 6 month follow-up, and 12 month follow-up

Typical weekend drinking was assessed using the Daily Drinking Questionnaire (DDQ; Collins et al., 1985), which asked teens to indicate the number of drinks they consumed on a typical Friday and Saturday during the past 6 months. These two items were summed to create the number of typical weekend drinks. Higher scores indicate the teen consumed a higher number of drinks on a typical weekend.

GroupValue95% CI
MADD Materials0.53± 1.56
Surgeon General Materials0.53± 1.57
Active Control0.38± 1.23
Declining to Ride With Impaired Drivers Primary · T4 (12-months post-baseline)

Declining riding with impaired drivers was assessed with two items adapted from Hultgren et al (2018). Teens were asked to indicate the number of times they declined a ride from a driver that consumed alcohol and the number of times they declined a ride from a driver that consumed any drug other than alcohol (e.g., marijuana, opioids) in the past 6 months. Responses were summed to indicate the number of times they declined rides from impaired drivers in the past 6 months. Higher scores indicate the participant declined more rides from impaired drivers.

GroupValue95% CI
MADD Materials0.61± 1.56
Surgeon General Materials0.56± 1.38
Active Control0.31± 0.99
Willingness to Ride in a Car With an Impaired Driver Secondary · Baseline, 6 month follow-up, and 12 month follow-up

Willingness to ride in a car with an impaired driver was assessed with two items adapted from Hultgren et al. (2018). Teens responded using a 7-point scale that ranged from (0) Strongly disagree to (6) Strongly agree on their level of agreement to the following statements, "I am willing to be a passenger in a vehicle when the driver has consumed alcohol." and "I am willing to be a passenger in a vehicle when the driver has consumed any drug other than alcohol (e.g., marijuana, ecstasy, opioids).". Responses were averaged to create a mean score. Higher scores indicate the participant is more wi

GroupValue95% CI
MADD Materials1.22± 0.03
Surgeon General Materials1.22± 0.03
Active Control1.22± 0.03

Sponsor's own description

Project MADD was designed to attempt to curb the alarming trends related to drunk driving and to move the field forward by testing a brief parent-intervention's ability to change adolescents' drinking, impaired driving, and riding with impaired driver behaviors. The aim of this project is to provide an easy-to-implement and low-cost alternative parent-based intervention that can be widely disseminated to address this important public health problem.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Penn State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03506880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing